Cytokinetics (CYTK) Insider Trading & Ownership $62.33 -0.53 (-0.84%) Closing price 04:00 PM EasternExtended Trading$62.30 -0.02 (-0.04%) As of 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Cytokinetics (NASDAQ:CYTK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$42.99M Get CYTK Insider Trade Alerts Want to know when executives and insiders are buying or selling Cytokinetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYTK Insider Buying and Selling by Quarter Cytokinetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type 10/22/2025 - 10/22/2026 Transaction Date Transaction Date From Transaction Date To 1M3M6MYTD1Y2Y3Y More filters Fewer filters Done 0 Results Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/20/2026Fady Ibraham MalikEVPSell3,500$64.01$224,035.00 10/12/2026Robert I BlumCEOSell7,500$62.88$471,600.00 10/6/2026Fady Ibraham MalikEVPSell3,500$61.38$214,830.00 9/29/2026Gilbert Ray Cisneros, Jr.House (D-CA)Buy$65.64$1,001 - $15,0009/28/2026Robert I BlumCEOSell7,500$65.46$490,950.00 9/22/2026Fady Ibraham MalikEVPSell3,500$68.29$239,015.00 9/15/2026Robert E LandryDirectorSell1,000$72.13$72,130.00 9/15/2026Robert I BlumCEOSell97,926$69.33$6,789,209.58 9/14/2026Robert I BlumCEOSell7,500$73.44$550,800.00 9/11/2026Robert E LandryDirectorSell1,000$74.66$74,660.00 9/8/2026Fady Ibraham MalikEVPSell3,500$75.46$264,110.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/1/2026B Lynne ParshallDirectorSell5,000$71.48$357,400.00 8/31/2026Andrew CallosEVPSell10,000$70.24$702,400.00 8/31/2026Robert I BlumCEOSell7,500$70.24$526,800.00 8/18/2026Fady Ibraham MalikEVPSell3,500$75.82$265,370.00 8/10/2026Robert I BlumCEOSell7,500$76.76$575,700.00 7/30/2026Andrew CallosEVPSell14,000$79.88$1,118,320.00 7/27/2026Robert I BlumCEOSell7,500$80.87$606,525.00 7/21/2026Fady Ibraham MalikEVPSell3,500$80.59$282,065.00 7/13/2026Robert I BlumCEOSell7,500$82.02$615,150.00 7/7/2026Fady Ibraham MalikEVPSell3,500$86.62$303,170.00 7/1/2026Andrew CallosEVPSell15,000$85.80$1,287,000.00 7/1/2026Robert I BlumCEOSell7,500$84.92$636,900.00 7/1/2026Sung LeeEVPSell1,112$87.79$97,622.48 6/30/2026Gilbert Ray Cisneros, Jr.House (D-CA)Buy$85.04$1,001 - $15,0006/29/2026Sung LeeEVPSell3,134$85.00$266,390.00 6/23/2026Fady Ibraham MalikEVPSell3,500$79.51$278,285.00 6/15/2026Robert I BlumCEOSell7,500$70.46$528,450.00 6/9/2026Fady Ibraham MalikEVPSell3,500$67.98$237,930.00 6/1/2026Andrew CallosEVPSell15,000$74.08$1,111,200.00 6/1/2026B Lynne ParshallDirectorSell5,000$74.08$370,400.00 6/1/2026Edward M Md KayeDirectorSell2,933$76.09$223,171.97 5/27/2026Robert I BlumCEOSell7,500$77.21$579,075.00 5/14/2026Robert I BlumCEOSell7,500$77.92$584,400.00 5/5/2026Fady Ibraham MalikEVPSell3,500$77.37$270,795.00 5/1/2026Andrew CallosEVPSell15,857$65.00$1,030,705.00 4/30/2026Andrew CallosEVPSell15,000$63.26$948,900.00 4/29/2026Robert I BlumCEOSell7,500$59.62$447,150.00 4/21/2026Fady Ibraham MalikEVPSell3,500$65.69$229,915.00 4/15/2026Andrew CallosEVPSell7,449$66.02$491,782.98 4/15/2026Robert I BlumCEOSell7,500$65.38$490,350.00 4/7/2026Fady Ibraham MalikEVPSell4,500$65.11$292,995.00 You haven't downloaded this yet (Ad)Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarter he swaps in a brand-new list, and once the new edition launches, this one disappears. Investors who want a current snapshot of his picks should grab a copy now and save it before the switch happens.Download your free copy before the new quarter's list replaces it3/18/2026Andrew CallosEVPSell1,930$62.07$119,795.10 3/17/2026Andrew CallosEVPSell8,542$62.15$530,885.30 3/17/2026Fady Ibraham MalikEVPSell12,033$62.15$747,850.95 3/17/2026Robert I BlumCEOSell36,601$62.15$2,274,752.15 3/17/2026Sung LeeEVPSell4,935$62.15$306,710.25 3/16/2026Andrew CallosEVPSell1,709$61.03$104,300.27 3/9/2026Andrew CallosEVPSell2,582$60.72$156,779.04 3/9/2026Fady Ibraham MalikEVPSell2,907$60.72$176,513.04 3/9/2026Robert I BlumCEOSell7,931$60.72$481,570.32 3/5/2026Andrew CallosEVPSell26,000$61.87$1,608,620.00 2/5/2026Andrew CallosEVPSell15,000$61.93$928,950.00 2/2/2026Andrew CallosEVPSell886$62.10$55,020.60 1/5/2026Andrew CallosEVPSell15,000$60.28$904,200.00 1/2/2026Andrew CallosEVPSell1,798$62.62$112,590.76 12/29/2025Andrew CallosEVPSell1,809$62.44$112,953.96 12/22/2025Wendell WierengaDirectorSell20,000$66.14$1,322,800.00 12/16/2025Fady Ibraham MalikEVPSell2,200$61.24$134,728.00 12/8/2025Andrew CallosEVPSell1,042$65.96$68,730.32 12/5/2025Andrew CallosEVPSell52,486$65.95$3,461,451.70 12/2/2025Fady Ibraham MalikEVPSell2,200$63.89$140,558.00 12/2/2025John T HendersonDirectorSell8,750$63.90$559,125.00 12/1/2025Edward M Md KayeDirectorSell28,064$66.72$1,872,430.08 12/1/2025Robert Arthur HarringtonDirectorSell2,150$66.80$143,620.00 11/19/2025B Lynne ParshallDirectorSell5,000$64.73$323,650.00 11/18/2025Fady Ibraham MalikEVPSell2,200$66.45$146,190.00 11/11/2025Edward M Md KayeDirectorSell5,175$65.08$336,789.00 11/4/2025Fady Ibraham MalikEVPSell2,295$59.55$136,667.25 10/30/2025Robert I BlumCEOSell5,000$62.86$314,300.00 10/27/2025Wendell WierengaDirectorSell4,375$58.68$256,725.00 (Data available from 1/1/2013 forward) CYTK Insider Trading Activity - Frequently Asked Questions Who is on Cytokinetics' Insider Roster? The list of insiders at Cytokinetics includes Andrew Callos, B Lynne Parshall, Edward M Md Kaye, Fady Ibraham Malik, John T Henderson, Muna Bhanji, Robert Arthur Harrington, Robert E Landry, Robert I Blum, Robert Wong, Sung Lee, Wendall Wierenga, and Wendell Wierenga. Learn more on insiders at CYTK. What percentage of Cytokinetics stock is owned by insiders? 2.60% of Cytokinetics stock is owned by insiders. Learn more on CYTK's insider holdings. Which Cytokinetics insiders have been selling company stock? The following insiders have sold CYTK shares in the last 24 months: Andrew Callos ($15,654,293.40), B Lynne Parshall ($1,051,450.00), Edward M Md Kaye ($3,661,087.25), Fady Ibraham Malik ($7,262,038.50), John T Henderson ($772,198.00), Muna Bhanji ($43,227.42), Robert Arthur Harrington ($161,363.50), Robert E Landry ($146,790.00), Robert I Blum ($21,549,127.09), Sung Lee ($670,722.73), Wendall Wierenga ($1,037,885.62), and Wendell Wierenga ($1,579,525.00). How much insider selling is happening at Cytokinetics? Insiders have sold a total of 867,151 Cytokinetics shares in the last 24 months for a total of $53,589,708.51 sold. Which members of congress are trading Cytokinetics? Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Cytokinetics in the last year totaling $16,000. Cytokinetics Active InsidersRobert I. Blum (Age 62)President and Chief Executive Officer13 recent tradesChing Jaw (Age 63)CFOSung LeeEVP, Chief Financial Officer2 recent tradesRobert Wong (Age 58)CAOSandford D SmithDirectorJohn T. HendersonDirectorL Patrick GageDirectorB Lynne ParshallDirector2 recent tradesWendall WierengaDirectorEdward M Md KayeDirector1 recent tradesSanto J CostaDirectorMuna BhanjiDirectorRobert Arthur HarringtonDirectorRobert E LandryDirector2 recent tradesFady Ibraham Malik (Age 61)EVP10 recent tradesAndrew Callos (Age 56)EVP6 recent tradesMark A Schlossberg (Age 65)SVPDavid Cragg (Age 70)Insider More Insider Trading Tools from MarketBeat Related Companies ROIV Insider Transactions GMAB Insider Transactions INCY Insider Transactions UTHR Insider Transactions BNTX Insider Transactions INSM Insider Transactions EXEL Insider Transactions ASND Insider Transactions HALO Insider Transactions BBIO Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles Intercepting Growth: Karman Secures $218M Lockheed Martin DealBoarding Now—GE Aerospace's Earnings Beat Comes With a CatchPowering Up: Applied Digital Execs Buy $6.7M in StockWired for Upside: Why Goldman Sachs Upgraded CoreWeave's Battered StockInsider Buying Is Rising at These 3 Regional Banks, But the Details Matter Insider trading data for NASDAQ:CYTK was last updated on 10/20/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
